Genentech had previously been number one by a very wide margin. This year, that margin started to narrow. Novartis is now a much closer second
Peter Carlin
Advertisement
Articles by Peter Carlin
Advertisement
Latest Updated Articles
The Total Customer ExperiencePublished: July 1st 2008 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
